GO:0051156 glucose 6-phosphate metabolic process: Metabolic Hub, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0051156 glucose 6-phosphate metabolic process describes all chemical reactions and pathways involving glucose 6-phosphate (G6P), a central metabolite at the crossroads of glycolysis, gluconeogenesis, the pentose phosphate pathway, and glycogen metabolism.
G6P is produced by hexokinase-mediated phosphorylation of glucose and is consumed by phosphoglucose isomerase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase, and the G6P transporter G6PT.
The process is essential for energy production, redox balance, nucleotide biosynthesis, and carbon storage, and its dysregulation is linked to metabolic, neurodegenerative, and infectious diseases.
Tissue-specific G6P pools and enzyme channeling allow distinct metabolic fates for G6P within the same cell, as shown in liver and heart models.
Pharmacological and genetic tools, including 2-deoxy-D-glucose and CRISPR-engineered cell models, enable precise dissection of G6P flux and its downstream effects.
Studying GO:0051156 requires integrating genetic, biochemical, and imaging approaches to resolve compartmentalized G6P metabolism and its role in health and disease.

Description

Glucose 6-phosphate (G6P) is a phosphorylated glucose derivative that sits at the heart of cellular carbon metabolism. The Gene Ontology term GO:0051156, glucose 6-phosphate metabolic process, encompasses all chemical reactions and pathways involving G6P, including its synthesis, interconversion, and utilization in diverse metabolic routes. This process is fundamental for maintaining energy homeostasis, providing reducing power and biosynthetic precursors, and storing or mobilizing glycogen. Researchers across cancer biology, neuroscience, infectious disease, and plant science study G6P metabolism because it directly influences cell fate, proliferation, and survival. Understanding the enzymes, transporters, and regulatory mechanisms that govern G6P levels is therefore critical for both basic discovery and therapeutic development.

glucose 6-phosphate metabolic process At A Glance

GO ID GO:0051156
GO term glucose 6-phosphate metabolic process
Ontology biological_process
Synonym glucose 6-phosphate metabolism; glucose 6-phosphate utilization
Definition The chemical reactions and pathways involving glucose 6-phosphate, a monophosphorylated derivative of glucose with the phosphate group attached to C-6.
Major function Central hub of carbohydrate metabolism, linking glycolysis, gluconeogenesis, pentose phosphate pathway, and glycogen metabolism.
Key enzymes Hexokinase, phosphoglucose isomerase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase, G6PT transporter.
Subcellular locations Cytosol, endoplasmic reticulum (via G6PT), and mitochondria-associated membranes.
Related pathways Glycolysis, pentose phosphate pathway, glycogen synthesis and degradation, gluconeogenesis.

What Is GO:0051156?

According to the Gene Ontology, GO:0051156 glucose 6-phosphate metabolic process is defined as the chemical reactions and pathways involving glucose 6-phosphate, a monophosphorylated derivative of glucose with the phosphate group attached to C-6. This includes the synthesis of G6P from glucose by hexokinases, its isomerization to fructose 6-phosphate, its oxidation in the pentose phosphate pathway, its hydrolysis to glucose, and its transport across membranes.

Why Is glucose 6-phosphate metabolic process Important in Cell Biology?

Glucose 6-phosphate metabolic process is essential for life because it determines how cells allocate glucose carbon to energy production, biosynthesis, and storage. Dysregulation of G6P metabolism contributes to cancer, diabetes, neurodegeneration, and infectious diseases, making it a prime target for therapeutic intervention and a critical area for understanding cellular physiology.
Provides energy via glycolysis and supports mitochondrial ATP generation.
Supplies NADPH and ribose-5-phosphate through the pentose phosphate pathway for redox balance and nucleotide synthesis.
Regulates blood glucose homeostasis through liver glucose-6-phosphatase and G6PT.
Supports plant growth and development by fueling biosynthetic pathways.
Is exploited by pathogens such as Plasmodium falciparum for their own metabolism.
Plays a role in β-amyloid clearance in microglia, linking metabolism to neurodegeneration.
Serves as a target for metabolic inhibitors like 2-deoxy-D-glucose in cancer and diagnostics.
Influences cardiac function through compartmentalized G6P pools.
Enables rapid adaptation to nutrient availability via allosteric and hormonal regulation.
Provides a model system for studying enzyme channeling and metabolic compartmentation.

What Happens During glucose 6-phosphate metabolic process?

Synthesis of glucose 6-phosphate
In simple terms: Glucose gets a phosphate tag added to it, trapping it inside the cell.
Glucose 6-phosphate is primarily synthesized by hexokinases, which phosphorylate glucose using ATP. In microglia, hexokinase 2 deficiency alters ATP generation and lipid metabolism, affecting β-amyloid clearance. In plants, HEXOKINASE1 is critical for fueling growth and development. This step commits glucose to intracellular metabolism.
Isomerization and glycolysis
In simple terms: G6P is rearranged into a similar molecule to continue the energy-producing pathway.
Phosphoglucose isomerase converts G6P to fructose 6-phosphate, a key step in glycolysis. Inhibition of this enzyme in heart muscle leads to G6P accumulation, revealing compartmentalized pools and regulatory feedback. This isomerization is essential for ATP production and metabolic flux.
Pentose phosphate pathway and NADPH production
In simple terms: G6P is used to make molecules that protect cells from damage and build DNA.
Glucose-6-phosphate dehydrogenase (G6PD) oxidizes G6P to 6-phosphogluconolactone, generating NADPH. This pathway is vital for redox homeostasis and nucleotide biosynthesis. Studies show that G6PD activity can be modulated by pharmacological agents, affecting cellular antioxidant capacity.
Hydrolysis and transport
In simple terms: G6P can be converted back to glucose or moved across membranes.
Glucose-6-phosphatase hydrolyzes G6P to glucose, enabling glucose release from liver and kidney. The G6P transporter G6PT moves G6P into the endoplasmic reticulum, and its structure and inhibition have been recently elucidated. These steps are critical for blood glucose regulation and metabolic integration.
Compartmentalization and channeling
In simple terms: G6P can be used in different ways depending on where it is in the cell.
Multiple G6P pools exist, and flux can be channeled into distinct pathways. As reviewed by Agius et al., G6P metabolism is not a single homogeneous pool but is compartmentalized, allowing simultaneous operation of glycolysis, pentose phosphate pathway, and glycogen synthesis. This organization ensures metabolic flexibility and efficiency.

Key Genes Involved in GO:0051156 glucose 6-phosphate metabolic process

The following genes and proteins are central to glucose 6-phosphate metabolic process, based on published literature.
GeneMajor RoleResearch Relevance
HK1Hexokinase 1, phosphorylates glucose to G6PPlant growth and development
HK2Hexokinase 2, phosphorylates glucose to G6PMicroglial metabolism and β-amyloid clearance
GPIGlucose-6-phosphate isomerase, converts G6P to F6PHeart muscle G6P accumulation
G6PDGlucose-6-phosphate dehydrogenase, produces NADPHRedox balance and drug effects
G6PCGlucose-6-phosphatase, hydrolyzes G6P to glucoseBlood glucose homeostasis
SLC37A4G6P transporter (G6PT), transports G6P into ERStructural and inhibition studies
PFKMPhosphofructokinase, muscle type, downstream of G6PGlycolytic flux regulation
PGIPhosphoglucose isomerase, same as GPIMetabolic compartmentation
TALDO1Transaldolase, pentose phosphate pathwayNADPH production
RPERibulose-5-phosphate epimerase, pentose phosphate pathwayNucleotide synthesis
GYS1Glycogen synthase, uses G6P-derived glucoseGlycogen storage
PYGLGlycogen phosphorylase, releases G6P from glycogenGlycogen metabolism
PDHA1Pyruvate dehydrogenase, links glycolysis to TCAEnergy metabolism
LDHALactate dehydrogenase, anaerobic glycolysisCancer metabolism
SLC2A1GLUT1, glucose transporter upstream of G6PGlucose uptake
SLC2A4GLUT4, insulin-responsive glucose transporterDiabetes research
GCKGlucokinase, liver hexokinase isoformBlood glucose sensing

How Is glucose 6-phosphate metabolic process Regulated?

Glucose 6-phosphate metabolic process is regulated at multiple levels. Hexokinases are inhibited by their product G6P, providing feedback control. Hormones such as insulin and glucagon modulate enzyme expression and activity, affecting G6P flux. The pentose phosphate pathway is regulated by NADP+/NADPH ratios, influencing G6PD activity. In heart muscle, phosphoglucose isomerase inhibition leads to G6P accumulation, demonstrating pathway-specific regulation. Additionally, the G6P transporter G6PT is regulated to control endoplasmic reticulum G6P levels.

glucose 6-phosphate metabolic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
HK2Alzheimer's disease (microglial metabolism)Hk2 knockout microglia
G6PDCancer, oxidative stressG6PD overexpression cell lines
G6PCGlycogen storage disease type IaG6pc knockout mice
SLC37A4Glycogen storage disease type IbG6PT mutant cells
GPIHeart failure (metabolic remodeling)Cardiomyocyte-specific Gpi knockout
Cancer metabolism
Many cancer cells exhibit increased glucose uptake and G6P metabolism to support rapid proliferation. 2-Deoxy-D-glucose, a G6P analog, is used to target glycolytic pathways and as a diagnostic agent. G6PD overexpression provides NADPH for biosynthesis and redox defense, contributing to tumor growth.
Neurodegeneration
Microglial hexokinase 2 deficiency alters G6P metabolism, increasing ATP generation through lipid metabolism and enhancing β-amyloid clearance, suggesting a protective role in Alzheimer's disease.
Infectious disease
Plasmodium falciparum relies heavily on glucose 6-phosphate metabolism for survival and proliferation, making these pathways potential antimalarial targets.
Metabolic disorders
Defects in glucose-6-phosphatase or G6PT cause glycogen storage diseases with severe hypoglycemia. Structural studies of G6PT provide insights for therapeutic development.

From glucose 6-phosphate metabolic process-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of hexokinase 2 affect microglial amyloid clearance?Hk2 knockout microglia
How does G6PD inhibition impact cancer cell redox balance?G6PD point-mutation knock-in
What is the role of G6PT in endoplasmic reticulum G6P transport?SLC37A4 knockout or tagged knock-in
Can overexpression of G6PC restore blood glucose?Liver-specific G6pc overexpression
How does phosphoglucose isomerase inhibition alter cardiac G6P pools?Inducible Gpi knockout in heart
Does HEXOKINASE1 overexpression enhance plant growth?Plant HK1 overexpression lines

How to Study the glucose 6-phosphate metabolic process Process

MethodWhat It MeasuresTypical Application
LC-MS metabolomicsG6P and metabolite levelsQuantify pathway flux
13C isotope tracingFlux through G6P pathwaysMetabolic reprogramming
Enzyme activity assayHexokinase, G6PD, G6Pase activityDrug screening
CRISPR knockoutGene function lossValidate metabolic genes
Cryo-EMProtein structureTransporter mechanism
Fluorescent biosensorsReal-time G6P dynamicsLive-cell imaging
RNA-seqTranscriptional changesPathway regulation
ProteomicsProtein expression and modificationsEnzyme abundance
Metabolomics and flux analysis
Mass spectrometry-based metabolomics quantifies G6P and related metabolites. Isotope tracing reveals flux through glycolysis, pentose phosphate pathway, and glycogen synthesis.
Enzyme activity assays
Spectrophotometric assays measure hexokinase, G6PD, and glucose-6-phosphatase activities in cell lysates or tissues, providing direct functional readouts.
Genetic manipulation and imaging
CRISPR knockout, knock-in, and overexpression models combined with fluorescent reporters allow visualization of G6P dynamics in live cells.
Structural biology
Cryo-EM and X-ray crystallography resolve structures of G6P transporters and enzymes, guiding inhibitor design.

How CRISPR Can Be Used to Study GO:0051156 glucose 6-phosphate metabolic process

Knockout

CRISPR knockout of genes such as HK2, G6PD, or SLC37A4 enables loss-of-function studies to determine their roles in G6P metabolism and disease. For example, Hk2 knockout microglia show altered ATP generation and amyloid clearance.

Point Mutation

Introducing specific point mutations (e.g., in G6PD or G6PT) allows structure-function analysis and modeling of human disease variants. This approach can reveal catalytic residues or regulatory sites.

Knock-in

Knock-in of tagged or reporter genes (e.g., GFP-tagged G6PT) facilitates localization and interaction studies. Knock-in of disease-associated mutations creates isogenic models for drug testing.

Overexpression

Overexpression of hexokinases or G6PD via CRISPR activation or lentiviral delivery boosts G6P flux, useful for studying metabolic reprogramming in cancer and other diseases.

How EDITGENE Supports glucose 6-phosphate metabolic process Research

Researchers studying glucose 6-phosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease progression, or therapeutic response. Precise genetic models are essential to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for glucose 6-phosphate metabolic process research.

Frequently Asked Questions About glucose 6-phosphate metabolic process

It is the set of chemical reactions and pathways involving glucose 6-phosphate, a central metabolite in carbohydrate metabolism, as defined by GO:0051156.
Key genes include HK1, HK2, GPI, G6PD, G6PC, and SLC37A4, among others.
It is produced by hexokinases, which phosphorylate glucose using ATP.
Cancer cells often increase G6P metabolism to support growth and redox balance, making it a therapeutic target.
In microglia, hexokinase 2 deficiency alters G6P metabolism and enhances β-amyloid clearance, suggesting a protective role.
Glycogen storage diseases, cancer, Alzheimer's disease, and malaria are among the conditions linked to G6P metabolism.
Metabolomics, isotope tracing, enzyme assays, and CRISPR screens are commonly used.
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools for dissecting gene function in this pathway.
G6PT, encoded by SLC37A4, transports glucose 6-phosphate into the endoplasmic reticulum and is linked to glycogen storage disease.
HEXOKINASE1 and G6P fuel biosynthetic pathways required for plant development.

Conclusion

Glucose 6-phosphate metabolic process (GO:0051156) is a central metabolic hub with far-reaching implications for energy homeostasis, biosynthesis, and disease. Understanding its regulation and genetic control offers opportunities for therapeutic intervention in cancer, neurodegeneration, and metabolic disorders. EDITGENE provides comprehensive CRISPR solutions to accelerate research in this vital area.

References

  1. 1. Leng L et al.. 2022. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance.. Nat Metab 4(10):1287-1305 PMID: 36203054
  2. 2. Preuss J et al.. 2012. Glucose-6-phosphate metabolism in Plasmodium falciparum.. IUBMB Life 64(7):603-11 PMID: 22639416
  3. 3. Vanderwall M et al.. 2023. HEXOKINASE1 and glucose-6-phosphate fuel plant growth and development.. Development 150(20) PMID: 37842778
  4. 4. Agius L et al.. 2002. Multiple glucose 6-phosphate pools or channelling of flux in diverse pathways?. Biochem Soc Trans 30(2):38-43 PMID: 12023820
  5. 5. Çalışkan B et al.. 2022. The effect of brimonidine and proparacaine on metabolic enzymes: Glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and glutathione reductase.. Biotechnol Appl Biochem 69(1):281-288 PMID: 33438819
  6. 6. Karlstaedt A et al.. 2020. Glucose 6-Phosphate Accumulates via Phosphoglucose Isomerase Inhibition in Heart Muscle.. Circ Res 126(1):60-74 PMID: 31698999
  7. 7. Pajak B et al.. 2019. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.. Int J Mol Sci 21(1) PMID: 31905745
  8. 8. Xia Z et al.. 2025. Structural basis for transport and inhibition of the human glucose-6-phosphate transporter G6PT.. Nat Commun 16(1):9420 PMID: 41136424
Contact Us
*
*
*
*
How did you hear about us: